secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2026-07-01T21:23:30+00:00
Accession:  0001213900-26-074421
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics raises $3M in private placement; warrants add up to $5.8M
-------------------------------------------------------------------------------

- Gross proceeds of $3M from sale of 960,000 pre-funded warrants at $3.1249/unit.
- Issued series C-1 and C-2 warrants to purchase up to 960,000 shares each at $3.00.
- Net proceeds to extend cash runway into Q1 2027; if warrants fully exercised, into H2 2027.
- H.C. Wainwright acted as exclusive placement agent; officers/directors subject to 60-day lock-up.
- Private placement closed July 1, 2026; securities unregistered, resale registration to be filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390026074421/0001213900-26-074421-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390026074421/ea0296666-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-074421

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer